Michael A. Gorin
Experienced in WT1-Related Wilms Tumor Syndromes

Dr. Michael A. Gorin

Urology
UPMC Western Maryland
12234 Williams Rd, 
Cumberland, MD 
Clinical Trials:Currently Recruiting for 1 Trial

Experienced in WT1-Related Wilms Tumor Syndromes
UPMC Western Maryland
12234 Williams Rd, 
Cumberland, MD 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael A. Gorin is a Urologist in Cumberland, Maryland. He has been an author of 279 peer-reviewed articles and participated in 4 clinical trials in the past 15 years. Dr. Gorin is a member of the Focal Therapy Society, Endourology Society, and an associate member of the American Urological Association. He is licensed to treat patients in Maryland and New York.

Dr. Gorin is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Oncocytoma, Prostate Cancer, Renal Cell Carcinoma (RCC), Nephrectomy, and Prostatectomy.

His clinical research consists of co-authoring 341 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Residency
Johns Hopkins University School of Medicine
Specialties
Urology
Licenses
Urology in MD
Board Certifications
American Board Of Urology
Hospital Affiliations
Mount Sinai South Nassau
Languages Spoken
English
Gender
Male
Awards
Star Reviewer for Urologic Oncology: Seminars and Original Investigation
William F. Rienhoff, Jr., M.D. Scholar Award, Johns Hopkins University School of Medicine
Best Reviewer Award, 32nd Annual Meeting of the Engineering & Urology Society
Resident Research Award, Annual Residency Retreat, The James Buchanan Brady Urological Institute

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Nippon Life
  • INSURANCE PLAN
Northwell Health
  • INSURANCE PLAN
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

UPMC Western Maryland
12234 Williams Rd, Cumberland, MD 21502
Call: 301-724-0132

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


9 Clinical Trials

Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer
Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer
Enrollment Status: Recruiting
Publish Date: September 11, 2025
Intervention Type: Procedure, Drug, Other, Radiation
Study Drugs: Abiraterone, Bicalutamide, Degarelix, Docetaxel, Flutamide, Goserelin acetate, Histrelin acetate, Leuprolide acetate, Nilutamide, Prednisone, Triptorelin
Study Phase: Phase 3
A Phase II Study to Evaluate the Performance of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate Cancer in Men With an Elevated PSA
A Phase II Study to Evaluate the Performance of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate Cancer in Men With an Elevated PSA
Enrollment Status: Active_not_recruiting
Publish Date: March 10, 2025
Intervention Type: Drug
Study Drug: 18F-DCFPyL Injection
Study Phase: Phase 2
Randomized Trial Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression
Randomized Trial Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression
Enrollment Status: Active_not_recruiting
Publish Date: February 27, 2025
Intervention Type: Other, Drug
Study Drug: Flutamide
Study Phase: Early Phase 1
A Phase II Randomized Trial of RAdium-223 and SABR Versus SABR for oligomEtastatic Prostate caNcerS (RAVENS)
A Phase II Randomized Trial of RAdium-223 and SABR Versus SABR for oligomEtastatic Prostate caNcerS (RAVENS)
Enrollment Status: Active_not_recruiting
Publish Date: November 04, 2024
Intervention Type: Drug, Radiation
Study Drug: Radium-223
Study Phase: Phase 2
A PrOspective Phase 2/3 Multi-Center Study of 18F-DCFPyL PET/CT Imaging in Patients With PRostate Cancer: Examination of Diagnostic AccuracY (OSPREY)
A PrOspective Phase 2/3 Multi-Center Study of 18F-DCFPyL PET/CT Imaging in Patients With PRostate Cancer: Examination of Diagnostic AccuracY (OSPREY)
Enrollment Status: Completed
Publish Date: August 09, 2021
Intervention Type: Diagnostic test, Drug
Study Phase: Phase 2/Phase 3
A Phase 3, Multi-Center, Open-Label Study to Assess the Diagnostic Performance and Clinical Impact of 18F-DCFPyL PET/CT Imaging Results in Men With Suspected Recurrence of Prostate Cancer
A Phase 3, Multi-Center, Open-Label Study to Assess the Diagnostic Performance and Clinical Impact of 18F-DCFPyL PET/CT Imaging Results in Men With Suspected Recurrence of Prostate Cancer
Enrollment Status: Completed
Publish Date: June 14, 2021
Intervention Type: Diagnostic test, Drug
Study Phase: Phase 3
Study of PSMA-targeted 18F-DCFPyL PET/CT in the Evaluation of Patients With Renal Cell Carcinoma
Study of PSMA-targeted 18F-DCFPyL PET/CT in the Evaluation of Patients With Renal Cell Carcinoma
Enrollment Status: Completed
Publish Date: April 29, 2020
Intervention Type: Drug, Procedure
Study Phase: Not Applicable
Study of 99mTc-Sestamibi SPECT/CT Imaging for the Preoperative Diagnosis of Renal Oncocytoma
Study of 99mTc-Sestamibi SPECT/CT Imaging for the Preoperative Diagnosis of Renal Oncocytoma
Enrollment Status: Completed
Publish Date: July 30, 2019
Intervention Type: Other
Study Phase: Not Applicable
A Phase 3 Study to Evaluate the Safety and Efficacy of 99mTc-MIP-1404 SPECT/CT Imaging to Detect Clinically Significant Prostate Cancer in Men With Biopsy Proven Low-Grade Prostate Cancer Who Are Candidates for Active Surveillance (proSPECT-AS)
A Phase 3 Study to Evaluate the Safety and Efficacy of 99mTc-MIP-1404 SPECT/CT Imaging to Detect Clinically Significant Prostate Cancer in Men With Biopsy Proven Low-Grade Prostate Cancer Who Are Candidates for Active Surveillance (proSPECT-AS)
Enrollment Status: Completed
Publish Date: April 10, 2019
Intervention Type: Drug, Diagnostic test
Study Phase: Phase 3
View 8 Less Clinical Trials

338 Total Publications

Case of the Month from the Icahn School of Medicine at Mount Sinai, New York, NY: MRI/TRUS fusion-guided biopsy of a local prostate cancer recurrence using the bladder for image registration.
Case of the Month from the Icahn School of Medicine at Mount Sinai, New York, NY: MRI/TRUS fusion-guided biopsy of a local prostate cancer recurrence using the bladder for image registration.
Journal: BJU international
Published: April 14, 2025
View All 338 Publications
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Jason P. Riley
Urology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Jason P. Riley
Urology

Allaway And Parousis Urology MD PA

12234 Williams Rd Se, 
Cumberland, MD 
 (1.1 miles away)
301-724-0132
Experience:
16+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jason Riley is an Urologist in Cumberland, Maryland. Dr. Riley has been practicing medicine for over 16 years and is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are UPJ Obstruction, Perirenal Abscess, Boils, Ureteroscopy, and Reconstructive Urology Surgery. Dr. Riley is currently accepting new patients.

Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Matthew J. Allaway
Urology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Matthew J. Allaway
Urology

Allaway And Parousis Urology MD PA

12234 Williams Rd Se, 
Cumberland, MD 
 (1.1 miles away)
301-724-0132
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Matthew Allaway is an Urologist in Cumberland, Maryland. Dr. Allaway is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Interstitial Cystitis, Ureteroscopy, and Prostatectomy. Dr. Allaway is currently accepting new patients.

Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Vasil X. Parousis
Urology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Vasil X. Parousis
Urology

Allaway And Parousis Urology MD PA

12234 Williams Rd Se, 
Cumberland, MD 
 (1.1 miles away)
301-724-0132
Languages Spoken:
English, Greek
See accepted insurances
Accepting New Patients

Vasil Parousis is an Urologist in Cumberland, Maryland. Dr. Parousis is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Eunuchoidism Familial Hypogonadotropic, Male Pseudohermaphroditism with Gynecomastia, Kidney Stones, Testicular Failure, and Ureteroscopy. Dr. Parousis is currently accepting new patients.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gorin's expertise for a condition
ConditionClose
  • Elite
  • Nephrectomy
    Dr. Gorin is
    Elite
    . Learn about Nephrectomy.
    See more Nephrectomy experts
  • Prostate Cancer
    Dr. Gorin is
    Elite
    . Learn about Prostate Cancer.
    See more Prostate Cancer experts
  • Renal Cell Carcinoma (RCC)
    Dr. Gorin is
    Elite
    . Learn about Renal Cell Carcinoma (RCC).
    See more Renal Cell Carcinoma (RCC) experts
  • Renal Oncocytoma
    Dr. Gorin is
    Elite
    . Learn about Renal Oncocytoma.
    See more Renal Oncocytoma experts
  • Distinguished
  • Familial Prostate Cancer
    Dr. Gorin is
    Distinguished
    . Learn about Familial Prostate Cancer.
    See more Familial Prostate Cancer experts
  • Obstructive Uropathy
    Dr. Gorin is
    Distinguished
    . Learn about Obstructive Uropathy.
    See more Obstructive Uropathy experts
  • Prostatectomy
    Dr. Gorin is
    Distinguished
    . Learn about Prostatectomy.
    See more Prostatectomy experts
  • Advanced
  • Bilateral Hydronephrosis
    Dr. Gorin is
    Advanced
    . Learn about Bilateral Hydronephrosis.
    See more Bilateral Hydronephrosis experts
  • Bladder Cancer
    Dr. Gorin is
    Advanced
    . Learn about Bladder Cancer.
    See more Bladder Cancer experts
  • Bladder Stones
    Dr. Gorin is
    Advanced
    . Learn about Bladder Stones.
    See more Bladder Stones experts
  • Boils
    Dr. Gorin is
    Advanced
    . Learn about Boils.
    See more Boils experts
  • Carbuncle
    Dr. Gorin is
    Advanced
    . Learn about Carbuncle.
    See more Carbuncle experts
  • Chromophobe Renal Cell Carcinoma
    Dr. Gorin is
    Advanced
    . Learn about Chromophobe Renal Cell Carcinoma.
    See more Chromophobe Renal Cell Carcinoma experts
View All 19 Advanced Conditions
  • Experienced
  • Asymptomatic Bacteriuria
    Dr. Gorin is
    Experienced
    . Learn about Asymptomatic Bacteriuria.
    See more Asymptomatic Bacteriuria experts
  • Balanitis
    Dr. Gorin is
    Experienced
    . Learn about Balanitis.
    See more Balanitis experts
  • Bladder Outlet Obstruction
    Dr. Gorin is
    Experienced
    . Learn about Bladder Outlet Obstruction.
    See more Bladder Outlet Obstruction experts
  • Bone Marrow Aspiration
    Dr. Gorin is
    Experienced
    . Learn about Bone Marrow Aspiration.
    See more Bone Marrow Aspiration experts
  • Clear Cell Sarcoma
    Dr. Gorin is
    Experienced
    . Learn about Clear Cell Sarcoma.
    See more Clear Cell Sarcoma experts
  • Cystectomy
    Dr. Gorin is
    Experienced
    . Learn about Cystectomy.
    See more Cystectomy experts
View All 46 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2025 All Rights Reserved